A Day Up For TMBR

TMBR (TMBR:NYSEMKT) soared at $1.52, representing a gain of 34.5%. On Tue 20 Oct 20, TMBR:NYSEMKT touched a New 2-Week High of $1.13. The stock appeared on our News Catalysts scanner on Fri 09 Oct 20 at 07:55 AM in the 'PATENT' category. From Tue 06 Oct 20, the stock recorded 60.00% Up Days and 72.73% Green Days

The share price of the company has been moving sideways in recent weeks.

About TMBR (TMBR:NYSEMKT)

Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. The company's investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. It is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), tuberous sclerosis complex (TSC), and localized scleroderma. Its development pipeline includes TMB-001 (Topical Isotretinoin), TMB-002 (Topical Rapamycin), and TMB-003 (Topical / Subcutaneous ET-A Receptor Antagonist).